AI Article Synopsis
- - The review aimed to determine if patients with bipolar disorder (BD) have a higher risk of stroke in comparison to those without BD.
- - An analysis of eight studies involving nearly 9.2 million participants found that BD patients have a significantly increased risk of stroke (HR: 1.60), but results varied due to factors like study location and sample size.
- - The conclusion suggests that while there is a clear risk for stroke among BD patients, the findings are limited by potential biases and differences among the studies, necessitating careful interpretation.
Article Abstract
Objective: The objective of the current review aimed to assess if patients with bipolar disorder (BD) have an increased risk of stroke.
Methods: A literature search was conducted on PubMed, Embase, ScienceDirect, and Web of Science for studies published from inception to 20 June 2023 and reporting the association between BD and stroke.
Results: Eight studies with 9187894 participants were eligible. Meta-analysis of all eight studies demonstrated that BD patients have an increased risk of stroke as compared to non-BD individuals (HR: 1.60 95% CI: 1.24, 2.05 I=94%). Results did not change in significance on sensitivity analysis. However, results varied on subgroup analysis based on study location, study type, sample size, and follow-up duration. The effect magnitude was unchanged based on the adjustment of diabetes and hypertension and study quality.
Conclusion: Patients with bipolar disorder (BD) may have an increased risk of stroke in comparison to the general population. The results are limited by the retrospective nature of the data and high inter-study heterogeneity which demand caution in the interpretation of the outcomes. PROSPERO (CRD42023434365), https://www.crd.york.ac.uk/prospero/.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11613353 | PMC |
| http://dx.doi.org/10.12669/pjms.40.11.10732 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Vitamin D and COVID-19: comparative analysis with other respiratory infections and impact of comorbidities.
Germs
September 2024
Pharm, PhD, Faculty of Pharmacy, Carol Davila University of Medicine and Pharmacy, No. 6 Traian Vuia street, Bucharest, 020956, Romania.
Introduction: The COVID-19 pandemic has promoted an intensive investigation into the pathophysiological mechanisms of SARS-CoV-2 infection, risk factors, and its impact on disease severity. Vitamin D has generated significant attention for its potential role in viral prevention and immune defense due to its pleiotropic functions, including immunomodulation and antimicrobial effects. This study aimed to assess serum 25(OH)D3 levels in patients with COVID-19 compared to those with other viral respiratory infections and to evaluate associations of vitamin D levels with symptomatology, clinical characteristics, presence of comorbidities and laboratory investigation.
View Article and Find Full Text PDFA Standardized Approach to Transition Improves Care of Young Adults with Inflammatory Bowel Disease.
Pediatr Qual Saf
January 2025
From the Division of Pediatric Gastroenterology, Hepatology and Nutrition, University of Miami, Miami, Fla.
Introduction: Young adults with inflammatory bowel disease (IBD) are at the risk of poor outcomes when transferring to adult providers. We aimed to increase the percentage of patients with 14-17 years of age undergoing the transition of care and the percentage of patients 18-21 years of age initiating the transfer of care to 50% for 12 months. Our goal was also to improve patient satisfaction with the transfer process.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!